AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ ३१.५९
arrow_downward
-०.५४%(-०.१७) 1D
नोभेम्बर १३, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ ३१.६४
High
US$ ३१.९७
Low
US$ ३०.८१
Mkt. cap
१.८९ अरब
Avg. vol.
१२.४९ लाख
Volume
३.७१ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ ३१.६४
High
US$ ३१.९७
Low
US$ ३०.८१
Mkt. cap
१.८९ अरब
Avg. vol.
१२.४९ लाख
Volume
३.७१ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
Yahoo! Finance Canada
·
६ मिनेट पहिले
AIRG,EML,DOMH,CULP,SLRC,FBK,VANI,HASI,ASYS,SFST,BRID,ASLE,RMCF,QRHC,CMTL,NVCT | Stock Prices | Quote Comparison - Yahoo Finance
The Motley Fool
·
१ घण्टा पहिले
History Says Every S&P 500 Bear Market Has Ended the Same Way. Here's the Pattern.
TheStreet
·
१३ मिनेट पहिले
Goldman Sachs reset S&P 500 price target for 2027
Bloomberg.com
·
२२ घण्टा पहिले
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc